Journal of Invasive Cardiology News

WASHINGTON—The American College of Cardiology (ACC),  The Society of Thoracic Surgeons (STS), and the Society for Cardiovascular Angiography and Interventions (SCAI), released the following joint statement on the transcatheter aortic valve...

Edwards Lifesciences issued the following statement in response to the national coverage determination (NCD) for transcatheter aortic valve replacement (TAVR) released by the Centers for Medicare & Medicaid Services (CMS).

The new tool, called ECG-CLIP, was trained using over 1.7 million ECGs collected from more than 540,000 people and paired with clinicians’ notes, embedding the tool with knowledge that may make it more adaptable for different disease...

Although lower Lp(a) levels were observed with pelacarsen, the findings did not demonstrate that this translated into reduced cardiovascular risk in the overall study population.

CMS estimates that aggregate Medicare payments for cardiovascular procedures performed in ASCs would increase 5% in 2027, compared with a 2% increase across ASC services overall, reflecting in part the relatively high proportion of...

Pi-Cardia's ShortCut™ device is the first FDA-cleared leaflet modification technology designed to enable valve-in-valve TAVR procedures in patients at risk of coronary obstruction.

SAN CLEMENTE, CA – September 1, 2026 – Reflow Medical, Inc. announced that the Centers for Medicare & Medicaid Services (CMS) has granted the Spur Peripheral Retrievable Stent System a New Technology Add-on Payment (NTAP), providing...

A world-first clinical trial conducted by Monash University researchers has shown that cholesterol-lowering medication can reduce heart attack and stroke in people aged over 70 years. 

MUNICH -- Caristo Diagnostics, a global leader in AI technologies for cardiovascular disease, announced new independent University of Oxford-led research presented at the European Society of Cardiology (ESC) Congress 2026 showing that...

Many people who survive a heart attack will later develop heart failure due to the scarring that occurs as the heart heals. Researchers at Uppsala University are now presenting a new type of biological treatment that is administered directly...